+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GCC IVF Market: Focus on Procedure, End User, Product, and 8 Countries' Data - Analysis and Forecast, 2023-2033

  • PDF Icon

    Report

  • 106 Pages
  • December 2023
  • Region: Middle East
  • BIS Research
  • ID: 5914382
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The healthcare landscape in the GCC region has undergone significant improvements, characterized by the proliferation of specialized fertility clinics providing advanced IVF treatments. This surge is complemented by supportive policies and regulations implemented by GCC governments, acknowledging the importance of reproductive health, and ensuring oversight of the IVF industry.

Technological advancements, such as preimplantation genetic testing (PGT) and in vitro maturation (IVM), have notably enhanced the success rates of fertility treatments in the GCC. The market further benefits from a growing trend in medical tourism, drawing individuals from neighbouring regions seeking accessible and high-quality IVF services within the GCC.

The GCC's IVF market stands at the threshold of ongoing expansion, propelled by shifting demographics, improved healthcare infrastructure, favourable regulatory environments, and continuous advancements in reproductive medicine. This sector is anticipated to play a pivotal role in addressing challenges related to infertility in the region.

Market Segmentation:

Segmentation 1: by Product

  • Systems
  • Media Reagent
  • Accessories and Consumables

Segmentation 2: by Type

  • Conventional IVF
  • IVF with Intracytoplasmic Sperm Injection (ICSI)

Segmentation 3: by Procedure

  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-Donor

Segmentation 4: by End-User

  • Commercial Labs
  • Fertility Clinics
  • Hospital Systems
  • Other End-User

Segmentation 5: by Country

  • Oman
  • Qatar
  • Saudi Arabia
  • United Arab Emirates
  • Kuwait
  • Bahrain

Key Questions Answered:

  • What was the market size of the GCC in-vitro fertilization market in 2022?
  • Which technique segment holds the highest dominance in the GCC in-vitro fertilization market?
  • Which segment exhibits the most dominance in the GCC in-vitro fertilization market?
  • What are the primary factors propelling the GCC in-vitro fertilization market?
  • What opportunities, risks, and overall market landscape characterize the in-vitro fertilization market?
  • What significant market trends are influencing the expansion of the in-vitro fertilization market?


This product will be delivered within 3-5 business days.

Table of Contents

1 Markets
1.1 Trends : Current and Future Impact Assessment
1.1.1 Trend 1
1.1.2 Trend 2
1.1.3 Trend 3
1.2 Supply chain Overview
1.2.1 Value Chain Analysis
1.2.2 Market Map
1.1.1 Pricing Forecast for Raw Materials and Components
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Company)
1.4 Regulatory Landscape
1.5 Stakeholder Analysis
1.5.1 Use case
1.6 Impact Analysis for Key Global Events- Covid-19
1.7 Market Dynamics Overview
1.7.1 Market Drivers
1.7.2 Market Restraints
1.7.3 Market Opportunities
2 Application
2.1 Application Segmentation
2.2 Application Summary
2.3 GCC IVF Market (by Procedure)
2.3.1 Overview
2.3.2 Fresh Donor
2.3.3 Fresh Non-Donor
2.3.4 Frozen Donor
2.3.5 Frozen Non-Donor
2.4 GCC IVF Market (by End-User)
2.4.1 Overview
2.4.2 Commercial Labs
2.4.3 Fertility Clinics
2.4.4 Hospital Systems
2.4.5 Other End-User
3 Products
3.1 Product Segmentation
3.2 Product Summary
3.3 GCC IVF Market (By Product)
3.3.1 Systems
3.3.1.1 Gamete Collection and Sorting Systems
3.3.1.2 Sample Handling Systems
3.3.1.3 Storage and Maintenance Systems
3.3.1.4 Other IVF System
3.3.2 Media Reagent
3.3.2.1 Embryo Culture Media and Reagents
3.3.2.2 Cryopreservation Media and Reagents
3.3.2.3 Gamete Processing Media and Reagents
3.3.2.4 Other Media and Reagents
3.3.3 Accessories and Consumables
3.4 GCC IVF Market (By Type)
3.4.1 Conventional IVF
3.4.2 IVF with Intracytoplasmic Sperm Injection (ICSI)
4 Countries
4.1 Regional Summary
4.2 Drivers and Restraints as you go alone……
4.3 United Arab Emirates
4.3.1 United Arab Emirates IVF Market by Application
4.3.2 United Arab Emirates IVF Market by Product
4.4 Saudi Arabia
4.4.1 Saudi Arabia IVF Market by Application
4.4.2 Saudi Arabia IVF Market by Product
4.5 Qatar
4.5.1 Qatar IVF Market by Application
4.5.2 Qatar IVF Market by Product
4.6 Oman
4.6.1 Oman IVF Market by Application
4.6.2 Oman IVF Market by Product
4.7 Kuwait
4.7.1 Kuwait IVF Market by Application
4.7.2 Kuwait IVF Market by Product
4.8 Bahrain
4.8.1 Bahrain IVF Market by Application
4.8.2 Bahrain IVF Market by Product
5 Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers…..
5.2 Geographic Assessment
5.2.1 The Cooper Companies
5.2.1.1 Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.1.7 Market Share
5.2.2 Fujifilm
5.2.2.1 Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.2.7 Market Share
5.2.3 Merck
5.2.3.1 Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.3.7 Market Share
5.2.4 Esco Lifesciences Group
5.2.4.1 Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.4.7 Market Share
5.2.5 The Baker Company, Inc
5.2.5.1 Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.5.7 Market Share
5.2.6 Al Hayat Pharmaceuticals
5.2.6.1 Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.6.7 Market Share
5.2.7 Biomerieux
5.2.7.1 Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.7.7 Market Share
5.2.8 Eppendorf
5.2.8.1 Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.8.7 Market Share
5.2.9 Corning Incorporated
5.2.9.1 Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.9.7 Market Share
5.2.10 Zeiss Group
5.2.10.1 Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.10.7 Market Share
5.2.11 Fertipro NV
5.2.11.1 Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.11.7 Market Share
5.2.12 Nidacon International AB
5.2.12.1 Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers
5.2.12.5 Key Personnel
5.2.12.6 Analyst View
5.2.12.7 Market Share
5.2.13 InVitroCare INC
5.2.13.1 Overview
5.2.13.2 Top Products / Product Portfolio
5.2.13.3 Top Competitors
5.2.13.4 Target Customers
5.2.13.5 Key Personnel
5.2.13.6 Analyst View
5.2.13.7 Market Share
5.2.14 Nikon Corporation
5.2.14.1 Overview
5.2.14.2 Top Products / Product Portfolio
5.2.14.3 Top Competitors
5.2.14.4 Target Customers
5.2.14.5 Key Personnel
5.2.14.6 Analyst View
5.2.14.7 Market Share
5.2.15 Olympus
5.2.15.1 Overview
5.2.15.2 Top Products / Product Portfolio
5.2.15.3 Top Competitors
5.2.15.4 Target Customers
5.2.15.5 Key Personnel
5.2.15.6 Analyst View
5.2.15.7 Market Share
6 Research Methodology
6.1 Data Sources
6.1.1 Primary Data Sources
6.1.2 Secondary Data Sources
6.1.3 Data Triangulation
6.2 Market Estimation and Forecast
List of Figures
Figure 1: Country Largest Share of Market
Figure 2: Pricing/Cost Analysis by Region, Supply Chain
Figure 3: GCC IVF Market, by Procedure, 2022, 2026 and 2033
Figure 4: GCC IVF Market, by End-User, 2022, 2026 and 2033
Figure 5: GCC IVF Market, By Technology, 2022, 2026 and 2033
Figure 6: GCC IVF Market, by Systems, 2022, 2026 and 2033
Figure 7: GCC IVF Market, Key events to keep track of
Figure 8: Supply chain and Identifying Risks within the Supply Chain
Figure 9: GCC IVF Market, By Country, January 2020-December 2023
Figure 10: GCC IVF Market, By Company, January 2020-December 2023
Figure 11: Impact Analysis of Market Navigating Factors
Figure 12: GCC IVF Market, 2002 and 2022
Figure 13: GCC IVF Market, 2002 and 2022
Figure 14: GCC IVF Market, 2002 and 2022
Figure 15: United Arab Emirates IVF Market, By End-User ($ Million), 2022, 2026, and 2033
Figure 16: United Arab Emirates IVF Market, By Systems ($ Million), 2022. 2026, and 2033
Figure 17: Saudi Arabia IVF Market, By End-User ($ Million), 2022, 2026, and 2033
Figure 18: Saudi Arabia IVF Market, By Systems ($ Million), 2022, 2026, and 2033
Figure 19: Qatar IVF Market, By End-User ($ Million), 2022, 206, and 2033
Figure 20: Qatar IVF Market, By Systems ($ Million), 2022, 2026, and 2033
Figure 21: Oman IVF Market, By End-User ($ Million), 2022, 2026, and 2033
Figure 22: Oman IVF Market, By Systems ($ Million), 2022, 2026, and 2033
Figure 23: Kuwait IVF Market, By End-User ($ Million), 2022, 2026, and 2033
Figure 24: Kuwait IVF Market, By Systems ($ Million), 2022, 2026, and 2033
Figure 25: Bahrain IVF Market, By End-User ($ Million), 2022, 2026, and 2033
Figure 26: Bahrain IVF Market, By Systems ($ Million), 2022, 2026, 2033
Figure 27: Strategic Initiatives, 2020 - 2023
Figure 28: Share of Strategic Initiatives
Figure 29: Data Triangulation
Figure 30: Top-Down and Bottom-Up Approach
Figure 31: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: GCC ICF Market, Opportunities
Table 3: GCC IVF Market, By Country, ($ Million), 2022-2033
Table 4: United Arab Emirates IVF Market, By End-User ($ Million), 2022-2033
Table 5: United Arab Emirates IVF Market, By Systems ($ Million), 2022-2033
Table 6: Saudi Arabia IVF Market, By End-User ($ Million), 2022-2033
Table 7: Saudi Arabia IVF Market, By Systems ($ Million), 2022-2033
Table 8: Qatar IVF Market, By End-User ($ Million), 2022-2033
Table 9: Qatar IVF Market, By Systems ($ Million), 2022-2033
Table 10: Oman IVF Market, By End-User ($ Million), 2022-2033
Table 11: Oman IVF Market, By Systems ($ Million), 2022-2033
Table 12: Kuwait IVF Market, By End-User ($ Million), 2022-2033
Table 13: Kuwait IVF Market, By Systems ($ Million), 2022-2033
Table 14: Bahrain IVF Market, By End-User ($ Million), 2022-2033
Table 15: Bahrain IVF Market, By Systems ($ Million), 2022-2033
Table 16: Market Share

Executive Summary

The GCC in-vitro fertilization market is set to witness significant growth, reveals the premium market intelligence study.

The GCC (Gulf Cooperation Council) region is experiencing a remarkable surge in the In Vitro Fertilization (IVF) market, signifying a paradigm shift in reproductive healthcare. The demand for IVF services has witnessed unprecedented growth, driven by factors such as increasing infertility rates, changing lifestyles, and a growing awareness of advanced fertility treatments.

Key Highlights of the Report:

Market Overview:

  • Analysis of the current market size and growth potential.
  • Identification of key market drivers, challenges, and opportunities.

Segmentation and Market Share:

  • Detailed segmentation based on product, end-user, procedure, and type.
  • Insights into the market share of major players and emerging trends.

Competitive Landscape:

  • Profiling of major players in the GCC in-vitro fertilization market.
  • Analysis of competitive strategies, partnerships, and mergers and acquisitions.

Forecast and Outlook:

  • Projection of market trends and growth prospects for the next ten years.
  • Insights into potential disruptions and factors influencing market dynamics.

Analyst Perspective

According to the Principal Analyst, 'The GCC IVF market is undergoing a transformative phase, driven by a combination of technological advancements, changing demographics, and supportive government policies. As the region continues to invest in cutting-edge fertility treatments, we anticipate sustained growth in the IVF market, offering new opportunities for both healthcare providers and patients.'

Key Questions Answered in this Report:

  • What was the market size of the GCC in-vitro fertilization market in 2022?
  • Which technique segment holds the highest dominance in the GCC in-vitro fertilization market?
  • Which segment exhibits the most dominance in the GCC in-vitro fertilization market?
  • What are the primary factors propelling the GCC in-vitro fertilization market?
  • What opportunities, risks, and overall market landscape characterize the in-vitro fertilization market?
  • What significant market trends are influencing the expansion of the in-vitro fertilization market?

Companies Mentioned

  • The Cooper Companies
  • Fujifilm
  • Merck
  • Esco Lifesciences Group
  • The Baker Company, Inc
  • Al Hayat Pharmaceuticals
  • Biomerieux
  • Eppendorf
  • Corning Incorporated
  • Zeiss Group
  • Fertipro NV
  • Nidacon International AB
  • InVitroCare INC
  • Nikon Corporation
  • Olympus